Shanghai Baoji Pharmaceutical Co., Ltd. focuses on the industrialization and commercialization of recombinant protein drugs and antibody drugs. We have built a cGMP-compliant production site in Shanghai, covering an area of about 63,000 square meters. We have planned multiple production lines covering mammalian cell expression systems and Escherichia coli and yeast expression systems, as well as finished production lines for water injections, freeze-dried powder injections, and disposable pre-encapsulated formulations.
相关临床试验
15
9 进行中
药物批准
1
批准总数
监管机构
1
监管机构数
成立时间
2019
进行中（未招募）
7
46.7%
已完成
2
13.3%
尚未招募
2
13.3%
招募中
4
26.7%
暂无资讯文章
